+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 19Years - 84Years
All Genders
ID04708587

Study Comparing Length of Dual Anti-Platelet Therapy Using Aspirin and Clopidogrel or Prasugrel After New Generation Drug-Eluting Stents in Adults with Advanced Chronic Kidney Disease

Led by Yonsei University · Updated on 2026-01-21

900

Participants Needed

1

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the best length of dual anti-platelet therapy using aspirin and either clopidogrel or prasugrel after placing new generation drug eluting stents in patients with advanced chronic kidney disease. This prospective, open-label, multicenter randomized clinical trial aims to compare clinical outcomes based on therapy duration in adults with chronic kidney disease stages IIIb to V. The study is led by Yonsei University and focuses on patients who have undergone percutaneous coronary intervention with these stents. Participants receive one of two treatments dual anti-platelet therapy with aspirin 100 mg plus either clopidogrel 75 mg or prasugrel 10 mg daily for at least 6 months, or the same therapy for 3 months or less followed by clopidogrel or prasugrel alone. The study compares these two groups over one year, assessing outcomes related to cardiovascular events and bleeding risks. During the study, participants are monitored for clinical events including net clinical adverse events, cardiovascular death, major adverse cardiovascular events, and bleeding complications over one year. Researchers will analyze data according to kidney disease stage, clinical presentation, and stent type. The total participation duration depends on follow-up assessments at regular intervals within the one-year period.

CONDITIONS

Brief Title

Appropriate Duration of Anti-Platelet straTegy in Patients With Advance Chronic Kidney Disease After New Generation Drug Eluting Stents (ADAPT-CKD)

Research Team

J

Jung-Sun Kim, MD, PhD, FESC

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here